Cargando…
Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)
BACKGROUND: A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program for certain medications with serious safety concerns required by the U.S. Food and Drug Administration (FDA) of manufacturers to implement to help ensure the benefits of the medication outweigh its risks. FDA is en...
Autores principales: | Huynh, Linda, Toyserkani, Gita A., Morrato, Elaine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348874/ https://www.ncbi.nlm.nih.gov/pubmed/34362367 http://dx.doi.org/10.1186/s12913-021-06808-3 |
Ejemplares similares
-
Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM
por: Toyserkani, Gita A., et al.
Publicado: (2020) -
Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response
por: Brewer, Sarah E., et al.
Publicado: (2019) -
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014) -
Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017) -
Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories
por: Morrison, Tina M., et al.
Publicado: (2018)